Original citation: JCI Insight. 2018;3(20):e120922. https://doi.org/10.1172/jci.insight.120922
Citation for this corrigendum: JCI Insight. 2018;3(23):e126138. https://doi.org/10.1172/jci.insight.126138
The molarity of the isotonic saline solution used was reported incorrectly in Figure 2A, Figure 3A, Figure 4B, the Methods section, and Supplemental Figure 7A. The correct molarity is 0.154 M. The correct sentence in Methods and the correct figure panels are below. The supplemental file has been updated.
Figure 2.
Figure 3.
Figure 4.
The authors regret the errors.
Methods
Control mice received isosmotic saline (0.154 M NaCl in ddH2O; 20 μl/g, i.p.). Hyperosmolality was induced either with mannitol (1 M in 0.34 M NaCl; 30 μl/g, i.p.) or HTS (1 M NaCl in ddH2O; 20 μl/g, i.p.).
Supplementary Material
Version 1. 12/06/2018
Electronic publication
Footnotes
See the related article at Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.